osphos 51 mg/ml inj. sol. i.m. vial
dechra regulatory b.v. - disodium clodronate tetrahydrate 74,98 mg/ml - eq. clodronic acid 51 mg/ml - solution for injection - 51 mg/ml - clodronate disodium tetrahydrate 74.98 mg/ml - clodronic acid - horse
osphos- clodronate disodium injection, solution
dechra veterinary products - clodronate disodium (unii: n030400h8j) (clodronic acid - unii:0813bz6866) - clodronate disodium 60 mg in 1 ml - indication: for the control of clinical signs associated with navicular syndrome in horses. contraindications: horses with hypersensitivity to clodronate disodium should not receive osphos. do not use in horses with impaired renal function or with a history of renal disease.
ostac cap 400mg capsule
hoffmann-la roche limited - clodronate disodium - capsule - 400mg - clodronate disodium 400mg - bone resorption inhibitors
clasteon capsule
sumitomo pharma canada, inc. - clodronate disodium - capsule - 400mg - clodronate disodium 400mg - bone resorption inhibitors
bonefos solution
bayer inc - clodronate disodium (clodronate disodium tetrahydrate) - solution - 60mg - clodronate disodium (clodronate disodium tetrahydrate) 60mg - bone resorption inhibitors
bonefos capsule
bayer inc - clodronate disodium (clodronate disodium tetrahydrate) - capsule - 400mg - clodronate disodium (clodronate disodium tetrahydrate) 400mg - bone resorption inhibitors
alendronsäure-ratiopharm plus colecalciferol 70 mg/5600 i.e. tabletten
alendronsäure-ratiopharm plus colecalciferol 70 mg/2800 i.e. tabletten
bonefos 60 mg/ml inf. sol. (conc.) i.v. amp.
bayer sa-nv - disodium clodronate tetrahydrate - eq. clodronate disodium 60 mg/ml - concentrate for solution for infusion - 300 mg - clodronate disodium 60 mg/ml - clodronic acid
bonefos 800 mg film-coat. tabl.
bayer sa-nv - disodium clodronate tetrahydrate - eq. clodronate disodium 800 mg - film-coated tablet - 800 mg - clodronate disodium 800 mg - clodronic acid